BMO Capital Markets highlighted the potential risks faced by Real Estate Investment Trusts (REITs) specializing in Skilled Nursing Facilities (SNFs) due to possible changes in Federal Medical ...
BMO Capital Markets reaffirmed their Outperform rating on Beam Therapeutics Inc (NASDAQ:BEAM), with a steady price target of $57.00. Currently trading at $26.57, the stock appears undervalued ...
BMO analysts are not convinced that Fluence Energy stock will swiftly recover as FLNC crashes after disappointing Q1 earnings.
BMO Capital downgraded Q32 Bio (QTTB) to Market Perform from Outperform with a price target of $3, down from $22. The company announced an ...
BMO Capital downgraded Fluence Energy (FLNC) to Market Perform from Outperform with a price target of $10, down from $22. The company’s Q1 ...
Verticals (NASDAQ:IIIV – Free Report) had its price target lifted by BMO Capital Markets from $22.00 to $26.00 in a research note released on Monday,Benzinga reports. They currently have a market ...
O’Reilly Automotive (NASDAQ:ORLY – Free Report) had its price target lifted by BMO Capital Markets from $1,400.00 to ...
WASHINGTON-President Trump on Monday announced 25% tariffs on imports of steel and aluminum to the U.S., reinstating global duties without exceptions for allies such as Canada, Mexico, Japan and South ...
Yields on U.S. government debt held to a tight range Monday despite President Donald Trump's plan to impose 25% tariffs on imports of steel and aluminum, with investors looking ahead to a busy week of ...
U.S. government debt was little changed overnight and into Monday morning, despite President Donald Trump's intention to impose 25% tariffs on all steel and alum ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results